Literature DB >> 24307297

Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium.

Sachiko Yamasaki1, Kou Nabeshima, Yusuke Sotomaru, Yuki Taguchi, Hanae Mukasa, Miho K Furue, J Denry Sato, Tetsuji Okamoto.   

Abstract

Mouse embryonic stem (mES) cells and mouse induced pluripotent stem (miPS) cells are commonly maintained on inactivated mouse embryonic fibroblast feeder cells in medium supplemented with fetal bovine serum or proprietary replacements. An undefined medium containing unknown quantities of reagents has limited the development of applications for pluripotent cells because of the relative lack of knowledge regarding cell responses to differentiating growth factors. Therefore we developed a serum-free medium, designated ESF7, in which mES cells can be maintained in an undifferentiated state without feeder cells. The medium was tested for culturing miPS cells. The miPS cells have been maintained in ESF7 medium for more than 3 years with an undifferentiated phenotype manifested by the expression of pluripotency marker genes and alkaline phosphatase, and these cells exhibited largely normal karyotypes. Furthermore, we found that fibroblast growth factor-2 (FGF-2) with heparin induced miPS cell differentiation into neuronal cells, both in an adherent monolayer and in embryoid body suspension culture. Moreover, we found that FGF-2 with bone morphogenetic protein 2 induced miPS cell differentiation into cardiomyocytes in embryoid body suspension culture. Furthermore, we transplanted subcutaneously miPS cells maintained in ESF7 into the dorsal flanks of SCID mice; all of the transplants produced tumors with tissues derived from all three embryonic germ layers. As this simple serum-free adherent monoculture system supports the long-term propagation of pluripotent iPS cells in vitro, it will allow us to elucidate cell responses to growth factors under defined conditions, and it should provide useful information for differentiation protocols for human iPS cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307297     DOI: 10.1387/ijdb.130173to

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  7 in total

1.  Improved approach for chondrogenic differentiation of human induced pluripotent stem cells.

Authors:  Hossein Nejadnik; Sebastian Diecke; Olga D Lenkov; Fanny Chapelin; Jessica Donig; Xinming Tong; Nikita Derugin; Ray C F Chan; Amitabh Gaur; Fan Yang; Joseph C Wu; Heike E Daldrup-Link
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 2.  Roles of FGF Signals in Heart Development, Health, and Disease.

Authors:  Nobuyuki Itoh; Hiroya Ohta; Yoshiaki Nakayama; Morichika Konishi
Journal:  Front Cell Dev Biol       Date:  2016-10-18

3.  The acceleration of cardiomyogenesis in embryonic stem cells in vitro by serum depletion does not increase the number of developed cardiomyocytes.

Authors:  Katarzyna Anna Radaszkiewicz; Dominika Sýkorová; Lucia Binó; Jana Kudová; Markéta Bébarová; Jiřina Procházková; Hana Kotasová; Lukáš Kubala; Jiří Pacherník
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

4.  Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions.

Authors:  Atsuko Hamada; Eri Akagi; Sachiko Yamasaki; Hirotaka Nakatao; Fumitaka Obayashi; Manami Ohtaka; Ken Nishimura; Mahito Nakanishi; Shigeaki Toratani; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-11-25       Impact factor: 2.416

5.  Identification of a familial cleidocranial dysplasia with a novel RUNX2 mutation and establishment of patient-derived induced pluripotent stem cells.

Authors:  Atsuko Hamada; Hanae Mukasa; Yuki Taguchi; Eri Akagi; Fumitaka Obayashi; Sachiko Yamasaki; Taku Kanda; Koichi Koizumi; Shigeaki Toratani; Tetsuji Okamoto
Journal:  Odontology       Date:  2021-11-15       Impact factor: 2.885

6.  Induction of Noonan syndrome-specific human-induced pluripotent stem cells under serum-, feeder-, and integration-free conditions.

Authors:  Atsuko Hamada; Eri Akagi; Fumitaka Obayashi; Sachiko Yamasaki; Koichi Koizumi; Manami Ohtaka; Ken Nishimura; Mahito Nakanishi; Shigeaki Toratani; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-02       Impact factor: 2.416

Review 7.  The Multifunctional Contribution of FGF Signaling to Cardiac Development, Homeostasis, Disease and Repair.

Authors:  Farhad Khosravi; Negah Ahmadvand; Saverio Bellusci; Heinrich Sauer
Journal:  Front Cell Dev Biol       Date:  2021-05-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.